Violence Is Their Only Answer
Protests Erupt In Greenland Over Trump's Plan to Acquire the Country
Trump Has Had Enough of Ilhan Omar and Her Hatred of America
Iranian President Is Now Threatening the US
Ah, So That's Why Kamala Harris Didn't Choose Josh Shapiro As Her Running...
The Media Proved How Truly Awful It Is by Posing This Question to...
The Netherlands Trying Integrating Migrants by Housing Them With Dutch Students. Guess Wha...
Goodbye, Kathleen Kennedy. You Won't Be Missed.
'You Didn't Build That:' Wealthy Journo Thinks California Is Entitled to Steal Billionaire...
This Amateur Hockey Player Died on the Ice. What He Saw Changed His...
Accurately Understanding King Jr.
RNC Chair Says Rising Left-Wing Radicalism Boosts Republicans for 2026 and 2028
ICE Confronts Protesters Protecting Child Sex Offender As Violence Escalates in Minnesota
You Won't Believe What Ilhan Omar Called the United States
Josh Shapiro Claims Harris Team Fixated on Israel, Questioned If He Was an...
Tipsheet

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’

AP Photo/Pablo Martinez Monsivais, File

Speaking during remarks to a J.P. Morgan healthcare conference this week, Pfizer CEO Albert Bourla openly stated current vaccines the company developed for Wuhan coronavirus offer "limited, if any" protection against contracting current variants of the disease. He then encouraged booster shots. 

The statement from Bourla comes as the Biden administration continues to justify vaccine mandates for federal workers, contractors and private businesses. The Supreme Court heard arguments about President Biden's mandates for private companies and medical workers last week. A ruling is expected soon on the constitutionality of the mandates. 

A number of people who have pointed out the waning efficacy of Pfizer's vaccines, which Bourla touted last year as being "100 percent" effective against contracting or transmitting the virus, have been banned by social media companies. 

Meanwhile, Bourla also announced this week the company is developing a vaccine specific to Omicron. It is expected to be ready in March when health officials predict the latest wave of the mild variant will already be over. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos